Why the study?
Does high on-treatment platelet reactivity to more than one agonist predict cardiovascular death and non-fatal MI in ACS patients undergoing PCI with stenting?
Population
1,108 acute coronary syndrome patients undergoing percutaneous coronary intervention with stent implantation
Comparison
High on-treatment platelet reactivity to more… vs Isolated platelet hyperreactivity to only one…
Design
Cohort
Follow-up
12 months
Authors
Loading...
May aid post-PCI risk stratification in ACS; hypothesis-generating and should not yet change practice.
Does high on-treatment platelet reactivity to more than one agonist predict cardiovascular death and non-fatal MI in ACS patients undergoing PCI with stenting?
High on-treatment platelet reactivity to multiple agonists (ADP, AA, collagen) is an independent predictor of 12-month cardiovascular death and non-fatal MI in ACS patients undergoing PCI.
Gori et al. (2010) studied this question.